Pfizer to Complete $43 Billion Acquisition of Seagen This Week and Launch New Oncology Division

Pfizer announced on December 12 local time that it expects to complete the acquisition of cancer drug maker Seagen for $43 billion later this week and plans to establish a new oncology division early next year. In addition, Pfizer's Chief Commercial Officer Angela Hwang will step down, and Pfizer will split its commercial operations, excluding oncology, into two divisions: the U.S. region and international. (Jiemian)Original Link